Therapeutic Modulation of the Immune Response in Arrhythmogenic Cardiomyopathy

Cited by (197)

Items 101–197 of 197

1. Targeting arrhythmogenic macrophages: lessons learned from arrhythmogenic cardiomyopathy
   Mesquita, Thassio, Cingolani, Eugenio · 2024 · Journal of Clinical Investigation
2. The Desmoplakin Phenotype Spectrum: Is the Inflammation the “Fil Rouge” Linking Myocarditis, Arrhythmogenic Cardiomyopathy, and Uncommon Autoinflammatory Systemic Disease?
   Saverio D’Elia, Adriano Caputo, Francesco Natale, Enrica Pezzullo, Giuseppe Limongelli, Paolo Golino, Giovanni Cimmino, Francesco S. Loffredo · 2024 · Genes
3. Analysis of effector/memory regulatory T cells from arrhythmogenic cardiomyopathy patients identified IL-32 as a novel player in ACM pathogenesis
   Salwa Soussi, Angela Serena Maione, Lise Lefèvre, Nathalie Pizzinat, Jason S. Iacovoni, Ignacio Gonzalez-Fuentes, Daniel Cussac, Lara Iengo, Yohan Santin, Fabrizio Tundo et al. · 2025 · Cell Death and Disease
4. NF‐kB signaling in cardiomyocytes is inhibited by sevoflurane and promoted by propofol
   Keiko Oda-Kawashima, Anna S. Sedukhina, Naoki Okamoto, Mariya Lytvyn, Kimino Minagawa, Teppei Iwata, Toshio Kumai, Eri Sato, Eiichi Inada, Ayako Yamaura et al. · 2020 · FEBS Open Bio
5. Integrated Strategies of Diverse Feature Selection Methods Identify Aging-Based Reliable Gene Signatures for Ischemic Cardiomyopathy
   Huafeng Song, Shaoze Chen, Tingting Zhang, Xiaofei Huang, Qiyu Zhang, Cuizhi Li, Chun‐Lin Chen, Shaoxian Chen, Dehui Liu, Jiawen Wang et al. · 2022 · Frontiers in Molecular Biosciences
6. Mechanisms of Innate Immune Injury in Arrhythmogenic Cardiomyopathy
   Stephen P. Chelko, Vinay R. Penna, Morgan Engel, Maicon Landim-Vieira, Elisa Nicole Cannon, Kory J. Lavine, Jeffrey E. Saffitz · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
7. Efficacy and Safety of Angiotensin Receptor Blockers in a Pre-Clinical Model of Arrhythmogenic Cardiomyopathy
   Landim-Vieira, Maicon, Kahmini, Aida Rahimi, Engel, Morgan, Cannon, Elisa Nicole, Amat-Alarcon, Nuria, Judge, Daniel P., Pinto, José Renato, Chelko, Stephen P. · 2022 · International Journal of Molecular Sciences
8. FDG PET/CT Imaging and Circulating Biomarkers of Inflammation in Desmoplakin Cardiomyopathy
   Sanjay Divakaran, Vinay Randhawa, Usman A. Tahir, Matthew S. Robertson, Anam Akbar Waheed, Anna Perillo, Leanne Barrett, Ron Blankstein, Mark W. Feinberg, Marcelo F. Di Carli et al. · 2024 · ESC Heart Failure
9. Using Zebrafish Animal Model to Study the Genetic Underpinning and Mechanism of Arrhythmogenic Cardiomyopathy
   Yujuan Niu, Yuanchao Sun, Yuting Liu, Ke Du, Xiaolei Xu, Yonghe Ding · 2023 · International Journal of Molecular Sciences
10. Reduced plakoglobin increases the risk of sodium current defects and atrial conduction abnormalities in response to androgenic anabolic steroid abuse
    Laura C. Sommerfeld, Andrew P. Holmes, Ting Yue Yu, Christopher O’Shea, Deirdre M. Kavanagh, Jeremy Andrew Pike, Thomas Wright, Fahima Syeda, Areej Aljehani, Tania Kew et al. · 2024 · The Journal of Physiology
11. Genetic Cardiomyopathies Misdiagnosed as Cardiac Sarcoidosis
    Muthiah Subramanian, V.V. Ravikanth, Daljeet Kaur Saggu, Sachin Dhareppa Yalagudri, Calambur Narasimhan · 2024 · JACC. Clinical electrophysiology
12. Animal Models and Molecular Pathogenesis of Arrhythmogenic Cardiomyopathy Associated with Pathogenic Variants in Intercalated Disc Genes
    Sara Vencato, Chiara Romanato, Alessandra Rampazzo, Martina Calore · 2024 · International Journal of Molecular Sciences
13. Inhibition of Soluble Epoxide Hydrolase Reduces Inflammation and Myocardial Injury in Arrhythmogenic Cardiomyopathy
    Dipak Panigrahy, Abigail G. Kelly, Katherine M. Quinlivan, Weicang Wang, Jun Yang, Sung Hee Hwang, Michael Gillespie, Isabella V. Howard, Carlos Bueno‐Betí, Angeliki Asimaki et al. · 2025 · JACC Basic to Translational Science
14. Proprotein convertase subtilisin/kexin type 9 links inflammation to vascular endothelial cell dysfunction
    Thorsten Martin Leucker, Nuria Amat-Codina, Stephen P. Chelko, Gary Gerstenblith · 2021 · European Heart Journal
15. Analysis of buccal mucosa as a prognostic tool in children with arrhythmogenic cardiomyopathy
    Carlos Bueno‐Betí, Ella Field, Adalena Tsatsopoulou, Gregory Perry, Mary Noelle Sheppard, Elijah Raphael Behr, Jeffrey E. Saffitz, Juan Pablo Kaski, Angeliki Asimaki · 2021 · Progress in Pediatric Cardiology
16. Gene-elusive arrhythmogenic cardiomyopathy: Roles of sports, inflammation, and beyond
    Lucas Tramèr, Ardan Muammer Saguner, Fernando G. Beltrami, Cynthia A. James, Hugh G Calkins, Fırat Duru · 2025 · Heart Rhythm
17. Endurance Training Provokes Arrhythmogenic Right Ventricular Cardiomyopathy Phenotype in Heterozygous Desmoglein-2 Mutants: Alleviation by Preload Reduction
    Larissa Fabritz, Lisa Fortmueller, Katja Gehmlich, Sebastian Kant, Marcel Kemper, Dana Kucerova, Fahima Syeda, Cornelius Faber, Rudolf E. Leube, Paulus F. Kirchhof et al. · 2024 · Biomedicines
18. Targeting Canonical Wnt-signaling Through GSK-3β in Arrhythmogenic Cardiomyopathy: Conservative or Progressive?
    Brandon Shu Huang Low, Angeliki Asimaki · 2024 · Journal of Cardiovascular Translational Research
19. Evaluation of autoantibodies to desmoglein-2 in dogs with and without cardiac disease
    Ashley L. Walker, Ronald H. L. Li, Nghi H. Nguyen, Carina E. Jauregui, Kathryn M. Meurs, Allison L. Gagnon, Joshua A. Stern · 2023 · Scientific Reports
20. Risk Assessment and Personalized Treatment Options in Inherited Dilated Cardiomyopathies: A Narrative Review
    Diana-Aurora Arnăutu, Octavian-Marius Cretu, Daniel Florin Lighezan, Minodora Andor, Ioana Citu, Dragoș Constantin Cozma, Brenda-Cristiana Bernad, Adrian-Pavel Trifa, Diana Lighezan, Elena-Silvia Bernad et al. · 2024 · Biomedicines
21. Desmosome-Dyad Crosstalk
    Mario Delmar, Francisco J. Alvarado, Héctor H. Valdivia · 2020 · Circulation
22. Arrhythmogenic cardiomyopathy: the ongoing search for mechanism-driven therapies meets extracellular vesicles
    Cristina Basso, Tania Zaglia, Kalliopi Pilichou · 2021 · European Heart Journal
23. Desmoplakin Haploinsu/iciency Underlies Cell-Cell Adhesion Failure in DSP Cardiomyopathy and is Rescued by Transcriptional Activation
    Eric D. Smith, Karen Jin, Brianna Ferguson, Yao-Chang Tsan, Samuel J. DePalma, Joshua K. Meisner, Aaron Renberg, Kenneth C Bedi, Sabrina Friedline, Kenneth B. Margulies et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
24. Hot phase episodes in arrhythmogenic cardiomyopathy: More than just a desmoplakin issue?
    Marika Martini, Alessandro Parodi, Maria Bueno Marinas, Ilaria Rigato, Rudy Celeghin, Luigi Filippo Brizzi, Annagrazia Cecere, Kalliopi Pilichou, Barbara Bauce · 2025 · Trends in Cardiovascular Medicine
25. Evaluation of Tideglusib as a Disease Modifying Therapy in Murine Models of Arrhythmogenic Cardiomyopathy
    Malhotra, Nipun, Cavus, Omer, Wallace, Michael J., Bobik, John T., You, Kevin, Takenaka, Sarah S., Abdallah, Danielle, Mohler, Eleanor J., Antwi-Boasiako, Steve, Murphy, Nathaniel P. et al. · 2025 · JACC: Basic to Translational Science
26. Apremilast improves cardiomyocyte cohesion and arrhythmia in different models for arrhythmogenic cardiomyopathy
    Konstanze Stangner, Orsela Dervishi, Janina Kuhnert, Carl Wendt, Soumyata Pathak, Maria Shoykhet, Silvana Olivares‐Florez, Sina Moztarzadeh, Jens Opsteen, Ni Luh Cathrin Suniasih Wohlfarth et al. · 2025 · Stem Cell Research & Therapy
27. Acute binge alcohol increases risk of arrhythmias and myocardial fibrosis in a mouse model of arrhythmogenic cardiomyopathy
    Emily A. Shiel, Waleed Farra, Steven Lee Medarev, Gallage H. D. Nipun Ariyaratne, Elisa Nicole Cannon, Jennifer L. Steiner, Stephen P. Chelko · 2025 · American Journal of Physiology-Heart and Circulatory Physiology
28. Cardiomyocyte cohesion is increased after ADAM17 inhibition
    Maria Shoykhet, Jens Waschke, Sunil Yeruva · 2023 · Frontiers in Cell and Developmental Biology
29. Circadian and Seasonal Pattern of Arrhythmic Events in Arrhythmogenic Cardiomyopathy Patients
    Silvia Castelletti, Michele Orini, Annina Salome Vischer, William John McKenna, Pier David Lambiase, Antonios A. Pantazis, Lia Crotti · 2023 · International Journal of Environmental Research and Public Health
30. In Vivo Approaches to Understand Arrhythmogenic Cardiomyopathy: Perspectives on Animal Models
    Giovanni Risato, Raquel Brañas Casas, Marco Cason, Maria Bueno Marinas, Serena Pinci, Monica De Gaspari, Silvia Visentin, Stefania Rizzo, Gaetano Thiene, Cristina Basso et al. · 2024 · Cells
31. Cardiomyocyte cytosolic nuclear self-DNA contributes to the pathogenesis of desmoplakin cardiomyopathy
    Weiyue Wang, Benjamin Cathcart, Quoc D. Nguyen, Loi Q. Lao, Amelia Bryans, Sara E Coleman, Leila Rouhi, Priyatansh Gurha, Ali J. Marian · 2025 · JCI Insight
32. Inflammation and Genetics in Myo-Pericardial Diseases: Insights from the Italian Study Group on Cardiomyopathies and Pericardial Diseases
    Marco Merlo, Giulia Bassetto, Antonio Nicola Cannata, Alberto Aimo, Camillo Autore, Barbara Bauce, Elena Biagini, Francesco Cappelli, Silvia Castelletti, Flavio D’Ascenzi et al. · 2025 · ESC Heart Failure
33. Misdiagnosed myocarditis in arrhythmogenic cardiomyopathy induced by a homozygous variant of DSG2: a case report
    Xuwei Liu, Yue Zhang, Wenjuan Li, Qian Zhang, Letao Zhou, Yimin Hua, Hongyu Duan, Yifei Li · 2023 · Frontiers in Cardiovascular Medicine
34. Cardiomyocyte and stromal cell cross-talk influences the pathogenesis of arrhythmogenic cardiomyopathy: a multi-level analysis uncovers DLK1-NOTCH pathway role in fibro-adipose remodelling
    Maione, Angela Serena, Iengo, Lara, Sala, Luca, Massaiu, Ilaria, Chiesa, Mattia, Lippi, Melania, Ghilardi, Stefania, Florindi, Chiara, Lodola, Francesco, Zaza, Antonio et al. · 2024 · Cell Death Discovery
35. The application of autopsy and explanted heart samples in scientific research
    Xiaorui Liu, Jiangping Song · 2022 · Cardiovascular Pathology
36. Episodic Myocarditis in Arrhythmogenic Cardiomyopathy
    Eric D. Smith, Adam S. Helms · 2022 · JACC Case Reports
37. Use of Sirolimus, an mTOR Inhibitor, to Treat Sarcoidosis in Multiple Systems
    Liam McGuire, Roxxy Brown, Angeliki Asimaki · 2025 · Journal of Cardiovascular Translational Research
38. Adipocyte-Mediated Electrophysiological Remodeling of PKP-2 Mutant Human Pluripotent Stem Cell-Derived Cardiomyocytes
    Justin B.F. Morrissette-McAlmon, Christianne J. Chua, Alexander Arking, Stanley Chun Ming Wu, Roald Teuben, Elaine Zhelan Chen, Leslie Tung, Kenneth R. Boheler · 2024 · Biomedicines
39. Advances in arrhythmogenic cardiomyopathy modeling using human-induced pluripotent stem cell-based models
    Dylan Mostert, Sabina Ferron, Claudia Vittoria Olmeda, Alessandra Rampazzo, Martina Calore · 2025 · Heart Rhythm
40. Circulation and Contacts in Sixteenth Century New Cartography: Spain, Portugal and Italy
    José María Moreno Madrid · 2021 · Culture & History Digital Journal
41. Elucidating arrhythmogenic right ventricular cardiomyopathy with stem cells
    Kenneth R. Laurita, Sunil K. Vasireddi, Judith A. Mackall · 2022 · Birth Defects Research
42. Plasma CCL3 predicts adverse heart failure outcomes in patients with arrhythmogenic cardiomyopathy
    Hao Cui, Songren Shu, Ningning Zhang, Mangyuan Wang, Tianshuo Yang, Zhen Wang, Xiao Chen, Mengxia Fu, Mengda Xu, Yicheng Yang et al. · 2025 · BMC Medicine
43. Human iPSC models of cardiac electrophysiology and arrhythmia
    Brenda Yang, Justin Lowenthal, Gordon F. Tomaselli, Leslie Tung · 2022 · Elsevier eBooks
44. Cardiomyocyte-specific plakophilin-2 loss is sufficient to induce aging and senescence of nonmyocytes. Relevance to arrhythmogenic cardiomyopathy
    Bertoli, Giorgia, Phadke, Kavya, Cospito, Alessandro, Rizk, Joanna Abi, Zhang, Mingliang, Miliotou, Eleni, Cammer, Michael, Deng, Yan, Mezzano, Valeria, Alu, Mark et al. · 2025
45. Cardiomyocyte‐Specific Plakophilin‐2 Loss Is Sufficient to Induce Aging and Senescence of Nonmyocytes: Relevance to Arrhythmogenic Cardiomyopathy
    2026
46. Maintenance of Energy Metabolism Is an Integral Part of Plakophilin-2 and Desmosome Functions
    J. Alex Aycinena, Anley E. Tefera, Isaac Perea‐Gil, Duncan Holbrook‐Smith, Kevin Williams, Reva Shenwai, Farshad Farshidfar, Brendan M Ryback, Katelyn S. Foppe, Iris Wu et al. · 2025 · JACC Basic to Translational Science
47. Response by Gasperetti et al to Letter Regarding Article, “Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin Variants”
    Alessio Gasperetti, Giovanni Peretto, Cynthia A. James, Maurizio Pieroni, Adam S. Helms, Hugh G Calkins, Nisha Aggarwal Gilotra · 2026 · Circulation
48. Bioinformatics analysis of JUP in patients with acute myocardial infarction and its potential application in clinical prognostic evaluation
    Xinyue Deng, Ailing Shen, Leiying Jiang · 2025 · Frontiers in Cardiovascular Medicine
49. Management Strategies in Arrhythmogenic Cardiomyopathy across the Spectrum of Ventricular Involvement
    Yash M. Maniar, Nisha Aggarwal Gilotra, Paul J. Scheel · 2023 · Biomedicines
50. A Novel DSP Truncating Variant in a Family with Episodic Myocardial Injury in the Course of Arrhythmogenic Cardiomyopathy—A Possible Role of a Low Penetrance NLRP3 Variant
    Przemysław Chmielewski, Grażyna T. Truszkowska, Piotr Kukla, Joanna Zakrzewska‐Koperska, Mateusz Śpiewak, Małgorzata Stępień‐Wojno, Maria Bilińska, Anna Lutyńska, Rafał Płoski, Zofia T. Bilińska · 2020 · Diagnostics
51. Editorial commentary: Arrhythmogenic cardiomyopathy: An in-depth look at molecular mechanisms and clinical correlates
    Angeliki Asimaki · 2020 · Trends in Cardiovascular Medicine
52. A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease
    Ariyaratne, Gallage H. D. N., Villatore, Andrea, Peretto, Giovanni, Chelko, Stephen P. · 2026 · Cells
53. Концепция «горячей фазы» как клинической воспалительной манифестации повреждения миокарда при генетической кардиомиопатии: литературный обзор и клиническое наблюдение
    Т.Г. Вайханская · 2025 · Кардиология в Беларуси
54. Integrative genomic and literature assessment of desmoglein 2-related arrhythmogenic cardiomyopathy with Italian cohort validation
    2026
55. Machine learning models enhance detection of arrhythmogenic right ventricular cardiomyopathy
    Kwaku K. Quansah, Sean A. Murphy, Esther Kwon, Emma Anderson, Crystal Tichnell, Brittney A. Murray, Sean Paul Gaine, Alessio Gasperetti, Cynthia A. James, Hugh G Calkins et al. · 2026 · Machine Learning Health
56. ETS1 potentiates pancreatic Pyroptosis in mice with acute pancreatitis by regulating the NKIRAS1/NF-κB Axis
    Wenwen Xia, Huilan Su, Yisu Huang, Can Wen, Jianjun Zhou, Yan Hong Zhao · 2026 · International Immunopharmacology
57. Desmoglein-2 deficiency drives mitochondrial morphological remodeling in cardiomyocytes
    Alexandre Gonçalves, Elaine Zhelan Chen, Hosna Rastegarpouyani, Aurélia Araújo Fernandes, Inês Nuno Alves, Vasco Sequeira, Chulan Kwon, Stephen P. Chelko, Maicon Landim-Vieira · 2026 · American Journal of Physiology-Heart and Circulatory Physiology
58. Premature ventricular contractions as a target for arrhythmogenic right ventricular cardiomyopathy trials
    Alessio Gasperetti, Norman Stockbridge, Jason D. Roberts, Pyotr G. Platonov, Hugh G Calkins, Wojciech Zaręba, Andrew David Krahn, William John McKenna · 2026 · Heart Rhythm
59. Inhibition of Programmed Cell Death-1 in Cytotoxic CD8 + T Cells Exacerbates Pressure Overload–Induced Cardiac Injury
    Ming‐Ming Wu, Yu Sun, Yue Zhang, Yan-Chao Yang, Zhi-Xi He, Shuang Zhou, Xia Wang, Han Xiao, Miao Yu, Chang Miao et al. · 2026 · Circulation
60. Pathogenesis, Diagnosis and Risk Stratification in Arrhythmogenic Cardiomyopathy
    Maria Teresa Florio, Filomena Boccia, Erica Vetrano, Marco Borrelli, Thomas D Gossios, Giuseppe Palmiero · 2021 · Cardiogenetics
61. Characteristics and pharmacological responsiveness in hiPSC models of inherited cardiomyopathy
    Merel Gerritse, Willem B. van Ham, Chris N. Denning, Toon A.B. van Veen, Renée G. C. Maas · 2025 · Pharmacology & Therapeutics
62. Early cardiac inflammation as a driver of murine model of Arrhythmogenic Cardiomyopathy
    Keat‐Eng Ng, Paul J. Delaney, Delphine Thenet, Stephen Murtough, C.M. Webb, Elena Tsisanova, Sophie L. M. Walker, Joseph David Westaby, Daniel J. Pennington, Ryan Charles Pink et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
63. Innate Immune Signaling in Hearts and Buccal Mucosa Cells of Patients with Arrhythmogenic Cardiomyopathy
    Carlos Bueto-Beni, Alessandro Tafuni, Stephen P. Chelko, Mary Noelle Sheppard, Ella Field, Jennifer Tollit, Imogen Heenan, Annabelle Barnes, Matthew R.G. Taylor, Luisa Mestroni et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
64. Plakophilin-2 Coordinates Energy Metabolism and Contractility in Cardiomyocytes, Revealing Its Roles beyond Desmosomes
    J. Alex Aycinena, Anley E. Tefera, Isaac Perea‐Gil, Duncan Holbrook‐Smith, Kevin J. Williams, Reva Shenwai, Farshad Farshidfar, Brendan M Ryback, Katelyn S. Foppe, Iris Wu et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
65. Cytokine Status in Game Sports Athletes with Cardiomyopathy of Overstrain
    Evgeniy D. Kopylov · 2019 · Biomedical Journal of Scientific & Technical Research
66. Personalized Medicine in Arrhythmogenic Right Ventricular Cardiomyopathy
    Laurens P. Bosman · 2022
67. Arrhythmogenic Cardiomyopathy. Genes and Desmosomal Proteins
    Ana Ruiz, Ana Elorriaga, Amaia Arregi, Paula Mendoza, Abel Andrés, Roberto Sáez · 2022 · Revista Argentina de Cardiología
68. Miocardiopatía arritmogénica. Genes y proteínas desmosómicas
    Hernán Pantere, Mariano Tumarkin, Francisco Azzato, José Milei · 2022 · Revista Argentina de Cardiología
69. Detecting and Targeting Inflammation in Genetic Cardiomyopathies
    Sean Pinney, Douglas L. Mann · 2023 · JACC Basic to Translational Science
70. Prognostic Value of Circulating Biomarkers of Fibrotic Remodeling in Arrhythmogenic Cardiomyopathy
    Stephen P. Chelko · 2024 · Biomedicines
71. Unraveling “Hot Phases” of Arrhythmogenic Cardiomyopathy
    Shanshan Gao, Suet Nee Chen, Luisa Mestroni · 2025 · JACC Basic to Translational Science
72. A “Hot” Cardiomyopathy
    Gautam Sen, Elizabeth M. Wilson, Daniel M. Sado, Rachel Bastiaenen, Stefania Rosmini · 2025 · New England Journal of Medicine
73. Machine Learning Models Enhance Prediction of Arrhythmogenic Right Ventricular Cardiomyopathy
    Kwaku K. Quansah, Sean A. Murphy, Esther Kwon, Emma Anderson, Crystal Tichnell, Brittney Murray, Sean Gaines, Alessio Gasperetti, Cynthia A James, Hugh Calkins et al. · 2025 · medRxiv
74. Autoantibodies in patients with arrhythmogenic cardiomyopathy activate GSK-3β resulting in a loss of cardiomyocyte cohesion
    Soumyata Pathak, Konstanze Stangner, Ellen Kempf, Sina Moztarzadeh, Matthias Hiermaier, M Rauschmayer, Tatjana Williams, Andreas Stengl, Brenda Gerull, Ruth Biller et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
75. Editorial commentary: Inflammation and arrhythmias – the never-ending quest for actionable items
    Alessio Gasperetti, Pasquale Santangeli · 2025 · Trends in Cardiovascular Medicine
76. Desmoglein-2 deficiency results in cardiac dysfunction by compromising both Z-disc- and intercalated disc-mediated mechanotransduction
    Maicon Landim-Vieira, Vivek Jani, Emily Shiel, Hosna Rastegarpouyani, Morgan Engel, Flair Paradine Cullup, Ronnie Chastain, Waleed Farra, Weikang Ma, Christopher N. Toepfer et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
77. A zebrafish stable model of Galectin-3 to elucidate its role in Arrhythmogenic Cardiomyopathy
    Kalliopi Pilichou, Giovanni Risato, Rudy Celeghin, Marco Cason, Maria Bueno Marinas, Serena Pinci, Raquel Brañas Casas, Monica De Gaspari, Mila Della Barbera, Nicola Facchinello et al. · 2025 · Research Square
78. Arrhythmogenic Cardiomyopathy
    Kalliopi Pilichou, Cristina Basso, Domenico Corrado, Gaetano Thiene · 2025 · Elsevier eBooks
79. Developing Mouse Models to Identify Future Therapeutic Strategies in Arrhythmogenic Right Ventricular Cardiomyopathy
    Hiroshige Murata · 2025 · Circulation Journal
80. Additional file 5 of Single-cell RNA sequencing in donor and end-stage heart failure patients identifies NLRP3 as a therapeutic target for arrhythmogenic right ventricular cardiomyopathy
    Fu, Mengxia, Xiumeng Hua, Songren Shu, Xu, Xinjie, Zhang, Hang, Zhiming Peng, Mo, Han, Liu, Yanyun, Xiao Chen, Yicheng Yang et al. · 2024 · Figshare
81. Additional file 3 of Single-cell RNA sequencing in donor and end-stage heart failure patients identifies NLRP3 as a therapeutic target for arrhythmogenic right ventricular cardiomyopathy
    Fu, Mengxia, Xiumeng Hua, Songren Shu, Xu, Xinjie, Zhang, Hang, Zhiming Peng, Mo, Han, Liu, Yanyun, Xiao Chen, Yang, Yicheng et al. · 2024 · Figshare
82. Additional file 1 of Single-cell RNA sequencing in donor and end-stage heart failure patients identifies NLRP3 as a therapeutic target for arrhythmogenic right ventricular cardiomyopathy
    Fu, Mengxia, Xiumeng Hua, Songren Shu, Xu, Xinjie, Zhang, Hang, Zhiming Peng, Mo, Han, Liu, Yanyun, Chen, Xiao, Yicheng Yang et al. · 2024 · Figshare
83. Additional file 4 of Single-cell RNA sequencing in donor and end-stage heart failure patients identifies NLRP3 as a therapeutic target for arrhythmogenic right ventricular cardiomyopathy
    Fu, Mengxia, Xiumeng Hua, Songren Shu, Xu, Xinjie, Zhang, Hang, Zhiming Peng, Mo, Han, Liu, Yanyun, Chen, Xiao, Yang, Yicheng et al. · 2024 · Figshare
84. Additional file 6 of Single-cell RNA sequencing in donor and end-stage heart failure patients identifies NLRP3 as a therapeutic target for arrhythmogenic right ventricular cardiomyopathy
    Fu, Mengxia, Xiumeng Hua, Songren Shu, Xu, Xinjie, Zhang, Hang, Zhiming Peng, Mo, Han, Liu, Yanyun, Xiao Chen, Yang, Yicheng et al. · 2024 · Figshare
85. Additional file 7 of Single-cell RNA sequencing in donor and end-stage heart failure patients identifies NLRP3 as a therapeutic target for arrhythmogenic right ventricular cardiomyopathy
    Fu, Mengxia, Xiumeng Hua, Songren Shu, Xu, Xinjie, Zhang, Hang, Zhiming Peng, Mo, Han, Liu, Yanyun, Xiao Chen, Yang, Yicheng et al. · 2024 · Figshare
86. Additional file 2 of Single-cell RNA sequencing in donor and end-stage heart failure patients identifies NLRP3 as a therapeutic target for arrhythmogenic right ventricular cardiomyopathy
    Fu, Mengxia, Xiumeng Hua, Songren Shu, Xu, Xinjie, Zhang, Hang, Zhiming Peng, Mo, Han, Liu, Yanyun, Chen, Xiao, Yang, Yicheng et al. · 2024 · Figshare
87. Editorial commentary: The hot phases of arrhythmogenic cardiomyopathy: A burning issue
    Giorgia Bertoli, Marina Cerrone, Mario Delmar · 2026 · Trends in Cardiovascular Medicine
88. NETosis and Myeloperoxidase Promotes Inflammation and Cardiac Remodeling in Arrhythmogenic Cardiomyopathy
    Emily Shiel, Gallage H. D. Nipun Ariyaratne, Waleed Farra, Andrea Villatore, Elisa Nicole Cannon, Stephen P. Chelko · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
89. High‐Performance Prevascularized SHED‐Laden rGO@Hydrogel Achieves Optimized Diabetic Bone Defect Repair
    C J Zhang, Yiyuan Kang, Shulin Lai, Chunyi Wang, Guixin He, Kehui Jian, Suhan Yin, Xiner Tan, Xinru Zhou, Wenjing Liu et al. · 2026 · Advanced Science
90. Autoantibodies in Patients With Arrhythmogenic Cardiomyopathy Activate GSK ‐3β, Resulting in a Loss of Cardiomyocyte Cohesion
    Soumyata Pathak, Konstanze Stangner, Ellen Kempf, Sina Moztarzadeh, Matthias Hiermaier, Stephanie Wider, M Rauschmayer, Tatjana Williams, Andreas Stengl, Brenda Gerull et al. · 2026 · Acta Physiologica
91. Aconitum carmichaelii: a clinical-regulatory synthesis of traditional use, toxicological evidence, and global safety governance
    Ru Ya Tan, Pin Jun Ooi, XiangYang Xu, Xu Wei, Xu Wen, Qiyue Qiu, Mun Fei Yam · 2026 · Frontiers in Pharmacology
92. Prioritizing Discovery and Advancements in Arrhythmia Therapies
    Peter Hanna, Patrick M. Boyle, Jessica L. Caldwell, Mona El Refaey, William Rowland Goodyer, Shaan S. Khurshid, Olurotimi O. Mesubi, Joseph Alexander Palatinus, Anna Pfenniger, Olujimi Adeoluwa Ajijola et al. · 2026 · JACC. Clinical electrophysiology
93. Inflammatory Hot Phases in Arrhythmogenic Cardiomyopathy
    Mehrdad Zarghami, Neda Dianati Maleki, Sajieh Naddaf, Tarek Abdulhadi, Magdalena Grabos, Ali Kanan, Dinmukhammed Osser, Azadeh Mahdavinia, Shreya Gulati, Abhijeet Singh · 2026 · JACC Advances
94. Lipid Metabolism as a Therapeutic Target in Arrhythmogenic Cardiomyopathy: Emerging Therapeutic Implications of Lipid-Lowering Therapy
    Nicolò Pasini, Federico Barocelli, Alberto Bettella, Alessia Ristagno, Mattia Santoro, Eleonora Canu, Antonio Crocamo, Filippo Luca Gurgoglione, Laura Torlai Triglia, Francesca Russo et al. · 2026 · Reviews in Cardiovascular Medicine
95. Single nucleus RNA sequencing identifies PLXNA4 upregulation in end-stage arrhythmogenic right ventricular cardiomyopathy
    Bridget Simonson, Mark D. Chaffin, Yasmine Guedira, Talita Zahin Choudhury, Ling Xiao, Richard Ruan, Kirsten Schneider, Jessica Morris, Vera V. Koledova, Kenneth C. Bedi et al. · 2026 · iScience
96. Design and Optimization of Acridine-Based p65 G-Quadruplex Stabilizers for the Treatment of Inflammation-Induced Lung Injury and Ulcerative Colitis
    Chaoyue Chen, Yihang Wu, Haoyi Han, Wenyan Ma, Li Wan, Yishun Fan, Xiang Li, Kun Wang, Zhiguo Liu, Xiaohui Zheng · 2026 · Journal of Medicinal Chemistry
97. Temporal proteomics maps concealed-stage remodeling and reveals early mitochondrial alteration as an intervention target in a model of PKP2-arrhythmogenic cardiomyopathy
    Jonathan Samuel Achter, Mikkel Svenningsen, John F. Mulvey, Giorgia Bertoli, Emily Meyer, Gautam Yepuri, Mingliang Zhang, Ravichandran Ramasamy, Mario Delmar, Alicia Lundby · 2026 · Nature Cardiovascular Research